BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9848712)

  • 1. The extracellular thyrotropin receptor domain is not a major candidate for mutations in toxic thyroid nodules.
    Führer D; Kubisch C; Scheibler U; Lamesch P; Krohn K; Paschke R
    Thyroid; 1998 Nov; 8(11):997-1001. PubMed ID: 9848712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha protein gene in 31 toxic thyroid nodules.
    Führer D; Holzapfel HP; Wonerow P; Scherbaum WA; Paschke R
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3885-91. PubMed ID: 9360556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of thyroid-stimulating hormone receptor and Gsalpha mutations: in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis.
    Trülzsch B; Krohn K; Wonerow P; Chey S; Holzapfel HP; Ackermann F; Führer D; Paschke R
    J Mol Med (Berl); 2001; 78(12):684-91. PubMed ID: 11434721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shared sporadic and somatic thyrotropin receptor mutations display more active in vitro activities than familial thyrotropin receptor mutations.
    Lueblinghoff J; Eszlinger M; Jaeschke H; Mueller S; Bircan R; Gozu H; Sancak S; Akalin S; Paschke R
    Thyroid; 2011 Mar; 21(3):221-9. PubMed ID: 21190443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar prevalence of somatic TSH receptor and Gsalpha mutations in toxic thyroid nodules in geographical regions with different iodine supply in Turkey.
    Gozu HI; Bircan R; Krohn K; Müller S; Vural S; Gezen C; Sargin H; Yavuzer D; Sargin M; Cirakoglu B; Paschke R
    Eur J Endocrinol; 2006 Oct; 155(4):535-45. PubMed ID: 16990652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of TSH receptor and Gsalpha mutations in 45 autonomously functioning thyroid nodules in Japan.
    Nishihara E; Amino N; Maekawa K; Yoshida H; Ito M; Kubota S; Fukata S; Miyauchi A
    Endocr J; 2009; 56(6):791-8. PubMed ID: 19550078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel activating mutation in the thyrotropin receptor gene in an autonomously functioning thyroid nodule developed by a Japanese patient.
    Kosugi S; Hai N; Okamoto H; Sugawa H; Mori T
    Eur J Endocrinol; 2000 Oct; 143(4):471-7. PubMed ID: 11022192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rarity of oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in Japan.
    Takeshita A; Nagayama Y; Yokoyama N; Ishikawa N; Ito K; Yamashita T; Obara T; Murakami Y; Kuma K; Takamatsu J
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2607-11. PubMed ID: 7673402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitive Sequencing Analysis Suggests Thyrotropin Receptor and Guanine Nucleotide-Binding Protein G Subunit Alpha as Sole Driver Mutations in Hot Thyroid Nodules.
    Stephenson A; Eszlinger M; Stewardson P; McIntyre JB; Boesenberg E; Bircan R; Sancak S; Gozu HI; Ghaznavi S; Krohn K; Paschke R
    Thyroid; 2020 Oct; 30(10):1482-1489. PubMed ID: 32284013
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression of beta-arrestins in toxic and cold thyroid nodules.
    Voigt C; Holzapfel H; Paschke R
    FEBS Lett; 2000 Dec; 486(3):208-12. PubMed ID: 11119705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of TSHR/Gsα mutation-negative clonal hot thyroid nodules (HNs) in a Turkish cohort.
    Sancak S; Jaeschke H; Eren F; Tarcin O; Guellueoglu B; Sen LS; Sever Z; Gozu HI; Bircan R; Akalin S; Paschke R; Eszlinger M
    Horm Metab Res; 2011 Jul; 43(8):562-8. PubMed ID: 21773967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of constitutively activating somatic thyrotropin receptor mutations in a subset of toxic multinodular goiters.
    Holzapfel HP; Führer D; Wonerow P; Weinland G; Scherbaum WA; Paschke R
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4229-33. PubMed ID: 9398745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas.
    Russo D; Arturi F; Suarez HG; Schlumberger M; Du Villard JA; Crocetti U; Filetti S
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1548-51. PubMed ID: 8636365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer risk and clinicopathological characteristics of thyroid nodules harboring thyroid-stimulating hormone receptor gene mutations.
    Mon SY; Riedlinger G; Abbott CE; Seethala R; Ohori NP; Nikiforova MN; Nikiforov YE; Hodak SP
    Diagn Cytopathol; 2018 May; 46(5):369-377. PubMed ID: 29516685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two novel mutations in the sixth transmembrane segment of the thyrotropin receptor gene causing hyperfunctioning thyroid nodules.
    Gozu H; Avsar M; Bircan R; Claus M; Sahin S; Sezgin O; Deyneli O; Paschke R; Cirakoglu B; Akalin S
    Thyroid; 2005 Apr; 15(4):389-97. PubMed ID: 15876166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of G(alpha)(s) proteins and TSH receptor signalling in hyperfunctioning thyroid nodules with TSH receptor mutations.
    Holzapfel HP; Bergner B; Wonerow P; Paschke R
    Eur J Endocrinol; 2002 Jul; 147(1):109-16. PubMed ID: 12088927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does a Leu 512 Arg thyrotropin receptor mutation cause an autonomously functioning papillary carcinoma?
    Gozu H; Avsar M; Bircan R; Sahin S; Ahiskanali R; Gulluoglu B; Deyneli O; Ones T; Narin Y; Akalin S; Cirakoglu B
    Thyroid; 2004 Nov; 14(11):975-80. PubMed ID: 15671779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two rare TSH receptor amino acid substitutions in toxic thyroid adenomas.
    Nanba K; Usui T; Minamiguchi S; Mori Y; Watanabe Y; Honda K; Asato R; Nakao K; Kawashima ST; Yuno A; Tamanaha T; Tagami T; Naruse M; Akiyama Y; Shimatsu A
    Endocr J; 2012; 59(1):13-9. PubMed ID: 22001338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.
    Tonacchera M; Chiovato L; Pinchera A; Agretti P; Fiore E; Cetani F; Rocchi R; Viacava P; Miccoli P; Vitti P
    J Clin Endocrinol Metab; 1998 Feb; 83(2):492-8. PubMed ID: 9467563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic alterations in thyroid hyperfunctioning adenomas.
    Russo D; Arturi F; Wicker R; Chazenbalk GD; Schlumberger M; DuVillard JA; Caillou B; Monier R; Rapoport B; Filetti S
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1347-51. PubMed ID: 7714109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.